FIELD: biotechnologies.
SUBSTANCE: invention relates to field of biotechnology, virology and medicine. Composition includes polynucleotide coding immunogen HC V, which represents complex E1E2 with definite amino acid sequence, adsorbed on cationic microparticle and pharmaceutically acceptable filler. Also described is method of obtaining such composition and its application for stimulation of immune response in subject-vertebrate.
EFFECT: invention can be used for immunisation against hepatitis C.
29 cl, 7 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR IMMUNE RESPONSE STIMULATION (VARIANTS), METHODS FOR PRODUCTION AND USING THEREOF AND METHOD FOR IMMUNE RESPONSE STIMULATION USING THE SAME | 2002 |
|
RU2316347C2 |
| MICROPARTICLES FOR DELIVERY OF HETEROLOGOUS NUCLEIC ACIDS | 2001 |
|
RU2295954C2 |
| VACCINE COMPOSITION POTENTIATED WITH DNA AND ANTIGEN COMBINATION | 2002 |
|
RU2294212C2 |
| HEPATITIS C VIRUS (HCV) ASIALOGLYCOPROTEIN, IMMUNOGENIC COMPOSITION, METHOD OF INDUCTION OF IMMUNE RESPONSE, METHOD OF IMMUNE ASSAY | 1991 |
|
RU2175657C2 |
| METHOD OF PREPARING HCV PROTEINS USEFUL FOR USING IN VACCINE OR IMMUNE ANALYSIS, ASIALOGLYCOPROTEIN (VARIANTS), COMPOSITION FOR USING IN VACCINE OR IN IMMUNE ANALYSIS (VARIANTS), METHOD OF ASIALOGLYCOPROTEIN PURIFICATION AND A METHOD OF HCV CONTENT DECREASE OR ELIMINATION | 1991 |
|
RU2123528C1 |
| ANTI-HCV VACCINE | 2003 |
|
RU2323744C2 |
| CHEMERICAL ANTIGENES FOR VACCINE AGAINST HEPATITIS C VIRUS | 2013 |
|
RU2639504C2 |
| POLYPEPTIDE AND METHOD OF ITS SYNTHESIS, REAGENT FOR IMMUNO-ANALYSIS, METHOD OF ASSAY OF ANTIBODY PRESENCE, METHOD OF INDUCTION OF IMMUNE RESPONSE | 1992 |
|
RU2148587C1 |
| IMMUNOGENIC POLYPEPTIDE COMPOSITION, METHOD OF COMPOSITION PREPARING, METHOD OF PRODUCING AND METHOD OF ANTIBODY DETECTION, SET | 1992 |
|
RU2136311C1 |
| MUTANT ANTIGENS GAS57 AND GAS57 ANTIBODIES | 2008 |
|
RU2471497C2 |
